SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-025724
Filing Date
2022-07-11
Accepted
2022-07-11 17:01:15
Documents
14
Period of Report
2022-07-07
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ny20004305x11_8k.htm   iXBRL 8-K 42123
2 EXHIBIT 99.2 ny20004305x11_ex99-2.htm EX-99.2 12359
6 ny20004305x11_ex99-2logo.jpg GRAPHIC 61846
  Complete submission text file 0001140361-22-025724.txt   284443

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA inva-20220707.xsd EX-101.SCH 3911
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE inva-20220707_lab.xml EX-101.LAB 22544
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inva-20220707_pre.xml EX-101.PRE 16034
8 EXTRACTED XBRL INSTANCE DOCUMENT ny20004305x11_8k_htm.xml XML 4227
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 221077474
SIC: 2834 Pharmaceutical Preparations